Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IB Acquisition Corp. is a special purpose acquisition company (SPAC) formed to effect a merger, capital stock exchange, asset acquisition, or similar business combination. In May 2024, the company announced a definitive merger agreement with Agape ATP Corporation, a personalized medical and wellness company. Agape ATP focuses on disease prevention and health maintenance through its proprietary health supplements and wellness programs. The merger is intended to provide Agape ATP with additional capital to expand its operations and enhance its presence in the global healthcare market. The combined entity will leverage Agape's existing platform to deliver personalized health solutions. IB Acquisition Corp. is listed on the NASDAQ under the symbol IBAC.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IB Acquisition Corp..